Abstract
A potent new antimicrobial candidate drug that shares enzyme targets—but has alternate binding sites—with fluoroquinolones was featured during the poster summary session “Early New Antimicrobial Agents” at the 2014 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C., last September. Other promising drug candidates are several novel cephalosporins, including one that carries a siderophore, a β-lactamase inhibitor that helps to overcome resistance in pathogens to β-lactam antibiotics, and an antifungal agent with an unusual mechanism.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
